Recurrent Soft Tissue Sarcoma Recruiting Phase 2 Trials for Hydrogen (DB15127)
Indication | Status | Phase |
---|---|---|
DBCOND0105100 (Recurrent Soft Tissue Sarcoma) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03155620 | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) | Screening |
|